| Quarter | Score |
|---|---|
| 2013-Q2 | 54.0 |
| 2013-Q3 | 53.5 |
| 2013-Q4 | 54.7 |
| 2014-Q1 | 53.6 |
| 2014-Q2 | 52.7 |
| 2014-Q3 | 53.4 |
| 2018-Q1 | 59.5 |
| 2018-Q2 | 59.7 |
| 2018-Q3 | 61.5 |
| 2019-Q2 | 62.8 |
| 2022-Q1 | 62.7 |
| 2022-Q3 | 42.6 |
| 2022-Q4 | 57.7 |
| 2023-Q1 | 49.5 |
| 2023-Q2 | 64.2 |
| 2023-Q3 | 48.4 |
| 2023-Q4 | 36.0 |
| 2024-Q1 | 73.5 |
| 2024-Q2 | 73.9 |
| 2024-Q3 | 66.5 |
| 2024-Q4 | 50.7 |
| 2025-Q1 | 71.0 |
| 2025-Q2 | 73.6 |
| 2025-Q3 | 59.4 |
| 2025-Q4 | 48.0 |
Funds reducing exposure or consensus momentum fading
Trading 18.9% below funds' estimated purchase price
1 of 16 tracked funds hold TMO. Avg conviction: 0.4%. Net adding. First tracked at $579.45 (current -18.9% vs tracked).
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 16 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Third Point | 0.4% | New Buy |